Cite
Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part Ⅰ).
MLA
Almutairi, Mashan, et al. “Formulation and Evaluation of Inhaled Sildenafil-Loaded PLGA Microparticles for Treatment of Pulmonary Arterial Hypertension (PAH): A Novel High Drug Loaded Formulation and Scalable Process via Hot Melt Extrusion Technology (Part Ⅰ).” International Journal of Pharmaceutics, vol. 655, Apr. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2024.124044.
APA
Almutairi, M., Hefnawy, A., Almotairy, A., Alobaida, A., Alyahya, M., Althobaiti, A., Adel Ali Youssef, A., Elkanayati, R. M., Ashour, E. A., Smyth, H. D. C., & Repka, M. A. (2024). Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part Ⅰ). International Journal of Pharmaceutics, 655, N.PAG. https://doi.org/10.1016/j.ijpharm.2024.124044
Chicago
Almutairi, Mashan, Amr Hefnawy, Ahmed Almotairy, Ahmed Alobaida, Mohammed Alyahya, Abdulmajeed Althobaiti, Ahmed Adel Ali Youssef, et al. 2024. “Formulation and Evaluation of Inhaled Sildenafil-Loaded PLGA Microparticles for Treatment of Pulmonary Arterial Hypertension (PAH): A Novel High Drug Loaded Formulation and Scalable Process via Hot Melt Extrusion Technology (Part Ⅰ).” International Journal of Pharmaceutics 655 (April): N.PAG. doi:10.1016/j.ijpharm.2024.124044.